CD36 expression and lipid metabolism following an oral glucose challenge in South Asians

Table 2 Fasting metabolic indices and monocyte CD36 expression amongst South Asian volunteers

Characteristics of 29 South Asian volunteers	Median (interquartile range)
Plasma glucose (mmol/L)	5.09 (4.50, 5.47)
Serum NEFA (mmol/L)	0.416 (0.264, 0.514)
Serum cholesterol (mmol/L)	3.41 (2.95, 3.96)
Serum triglycerides (mmol/L)	0.9 (0.67, 1.44)
HDL cholesterol (mmol/L)	1.27 (0.98, 1.48)
LDL cholesterol (mmol/L)	2.03 (1.56, 2.44)
Apolipoprotein AI (g/L)	1.21 (1.10, 1.43)
Apolipoprotein B (g/L)	0.58 (0.46, 0.77)
VLDL subfraction cholesterol (mmol/L)	1.26 (0.97, 1.44)
LDL subfraction cholesterol (mmol/L)	1.3 (0.80, 1.65)
HDL2 subfraction cholesterol (mmol/L)	0.58 (0.41, 0.76)
HDL3 subfraction cholesterol (mmol/L)	0.37 (0.25, 0.51)
VLDL subfraction triglyceride (mmol/L)	0.34 (0.24, 0.43)
LDL subfraction triglyceride (mmol/L)	0.27 (0.17, 0.55)
HDL2 subfraction triglyceride (mmol/L)	0.08 (0.06, 0.15)
HDL3 subfraction triglyceride (mmol/L)	0.06 (0.04, 0.08)
Insulin (mU/L)	4.64 (2.60, 8.23)
Adiponectin (ng/mL)	1.79 (0.65, 2.65)
Plasma soluble CD36 (mmol/L)	108 (0, 249)
Total monocyte CD36 (Mon CD36+ per μL)	361 (301, 432)
Monocyte CD36 on Mon1 (%)	81.8 (75.1, 85.8)
Monocyte CD36 on Mon2 (%)	7.2 (5.0, 10.3)
Monocyte CD36 on Mon3 (%)	10.5 (8.7, 16.6)

Monocyte subset. Mon1: CD14(+)CD16(-)CCR2(+); Mon2: CD14(+)CD16(+)CCR2(+); Mon3: CD14(low)CD16(+)CCR2(-); NEFA: Non-esterified fatty acids; VLDL: Very low density lipoprotein; LDL: Low density lipoprotein; HDL: High density liporprotein.